Hello @hitesh2710 Sir, what is your view on general market direction as we move to start of new series. I observed divergence on RSI on all 4 major indices (Nifty, BNF, Mid and Small cap), do you see a big impending correction coming along soon on technical basis or any fundamental related to earnings disappointment? What variables you look into while getting a feel of general market direction?

Happy New Year everyone. My current portfolio has the following companies.

Every year I try new strategies. Some of investing strategies I have tried till now are:

• Index investing
• Absolute momentum portfolio
• Value investing
• IPO investing
• Special situations – Takeover and Rights issue
• Breakout strategy
• Buy and hold strategy
• Smallcase investing
• Relative momentum strategy
• Mutual funds
• Factor investing – direct and through ETF

I don’t have the temperament to follow these techniques. They do work for people who can follow them systematically. I have realized that buying growth stocks at reasonable valuations (GARP) has worked for me till now. I will try to continue following the same this year and keep distractions in control. May this year bring prosperity and joy to all.

Hello Everyone,
First of all, kudos on such great research on this topic. It is definitely quite insightful!
I had some questions regarding this sector. Coming from a non-science background, they might be a little basic but would really be helpful for me to delve deeper into this topic.

1. What is the next stage after the Clinical trials are done? And what might be the success rate of a drug clearing Phase III of these trials?
2. After the drug has received FDA approval, what shall be next step? Will the innovator company manufacture this drug on its own, or outsource/license other companies? How much % of revenue oppurtunity could Wockhardt have from the total market of this drug?
3. What could be the timeline for this drug (WCK 5222) to be in the market, my assumption is atleast 2 years. But since it is being used on humanitarian grounds already, can we expect the authorities to expedite the approval process?
   Thankyou so much!

I am also intrested in knowing more about the same.

As of now i think we can give loan to Huf by Karta or Member at a reasonable intrest rate after that the income generated from that loan amount will not be clubed in Lender’s income.

In case of gifts upto 50k without consederation are tax free under section 56 of income tax in one year above 50k it will be charged at normal slab rates. Once the Huf pay tax on these gifts above 50k the income generated on the gift amount will not be clubed in future.

Any news about Tommy Hilfigure licence renew…